Immunotherapeutic approaches to cancer treatment have gained significant traction in recent years, due in large part to the success of immune checkpoint inhibitors and T cell-based therapies. Comparative oncology is the study of naturally-occurring cancer in companion (pet) animals, mainly dogs, and is a powerful tool in cancer research and drug development. Given their intact,…
Veterinary oncology. Template
Write in a clean editor, then format for Veterinary oncology. in one click — DocuGuru applies the official BMC (BioMed Central) template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Veterinary oncology. format
Veterinary oncology. is a peer-reviewed journal published by BMC (BioMed Central), covering Veterinary Oncology Research, Virus-based gene therapy research, Veterinary Medicine and Surgery.
| Publisher | BMC (BioMed Central) |
|---|---|
| Reference style | Numbered (Vancouver) Numbered — [1], [2] in the text 1. Smith A, Jones B, Lee C. A representative article title. Veterinary oncology.. 2023;12(3):45–58.
Formats any DOI in Veterinary oncology. style. No sign-up. |
| Publishes research in | Veterinary Oncology Research Virus-based gene therapy research Veterinary Medicine and Surgery Infectious Diseases and Mycology Salivary Gland Tumors Diagnosis and Treatment |
| ISSN | 3004-9814 |
| Citation impact (2-yr) | 0.84 |
| h-index | 4 |
| i10-index | 1 |
| Total citations | 80 |
| Top institutions publishing here | Royal Veterinary College |
| Journal website | {https://veterinaryoncology.biomedcentral.com/,http://link.springer.com/journal/44356} |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Veterinary oncology. per year
Citation impact of Veterinary oncology. by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Veterinary oncology.
The high incidence of nodal metastasis, variable lymphatic drainage patterns, and prognostic significance of nodal metastasis in dogs with apocrine gland anal sac adenocarcinoma (AGASACA) highlight the need for development of standardized techniques for lymph node staging in canine AGASACA. The aim of this study was to develop and describe the utility of pre- and…
Canine cancer is a leading cause of canine deaths, often resulting from complex interactions between germline-risk genetics, somatic mutations, and environmental exposures. To help identify major dietary, genetic, and environmental exposure risk factors for canine cancer, Morris Animal Foundation launched the Golden Retriever Lifetime Study, the first prospective longitudinal study in veterinary medicine. We hypothesized…
The most common first-line treatment for canine lymphoma is a chemotherapy protocol that includes cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP). Canine high-grade T-cell lymphoma has been found to have a significantly poorer prognosis than high grade B-cell lymphoma. Several studies have investigated alternative protocols for non-indolent T-cell lymphoma. This retrospective study investigated using a cyclophosphamide,…
Abstract Canine malignant insulinoma is a rare, highly metastatic and life-threatening neuroendocrine tumour of pancreatic beta cells. To map the single-cell transcriptomic landscape of canine insulinoma for the first time, transcriptomic profiles of 5,532 cells were captured from two spontaneous insulinomas (Patient 1 and 2) and one associated metastasis (Patient 2) in two Boxer dogs.…